Sollinger H W, Knechtle S J, Reed A, D'Alessandro A M, Kalayoglu M, Belzer F O, Pirsch J
University of Wisconsin, School of Medicine, Department of Surgery, Madison.
Ann Surg. 1991 Dec;214(6):703-11. doi: 10.1097/00000658-199112000-00010.
From December 1985 to December 1989, 100 consecutive simultaneous pancreas-kidney (SPK) transplants were performed at the University of Wisconsin Hospital and Clinics. Bladder drainage technique was used for all grafts. One- and three-year patient survival was 93% and 90%; kidney survival, 90% and 85%; and pancreas survival, 86% and 84%. Quadruple immunosuppressive therapy was used in all patients and consisted of either MALG or OKT3 induction, and cyclosporine, prednisone, and azathioprine maintenance therapy. OKT3 induction therapy was used in 42 patients and Minnesota antilymphocyte globule in 58 patients, with equivalent results except for more opportunistic infection with OKT3. The duodenal button technique was used in the first 17 patients with systemic anticoagulation and was associated with significantly more postoperative bleeding and infection compared with the duodenal segment technique. The most common surgical complication of the duodenal segment technique was urine leak (13%), which usually occurred from the distal duodenal segment. The most common urologic complication of bladder drainage was hematuria (13%), which was usually self-limited. Within 6 months of transplantation, 84% of patients developed urinary tract infections, and 25% of patients had opportunistic infections. The surgical techniques and immunosuppressive methods used in this series are reviewed, and strategies for preventing medical and surgical complications are outlined.
1985年12月至1989年12月期间,威斯康星大学医院及诊所连续进行了100例胰肾联合移植手术。所有移植物均采用膀胱引流技术。患者1年和3年生存率分别为93%和90%;肾脏生存率分别为90%和85%;胰腺生存率分别为86%和84%。所有患者均采用四联免疫抑制疗法,诱导治疗采用MALG或OKT3,维持治疗采用环孢素、泼尼松和硫唑嘌呤。42例患者采用OKT3诱导治疗,58例患者采用明尼苏达抗淋巴细胞球蛋白诱导治疗,除OKT3治疗后机会性感染较多外,结果相当。前17例患者采用十二指肠纽扣技术并进行全身抗凝,与十二指肠节段技术相比,术后出血和感染明显更多。十二指肠节段技术最常见的手术并发症是尿漏(13%),通常发生在十二指肠远端节段。膀胱引流最常见的泌尿系统并发症是血尿(13%),通常为自限性。移植后6个月内,84%的患者发生尿路感染,25%的患者发生机会性感染。本文回顾了本系列中使用的手术技术和免疫抑制方法,并概述了预防内科和外科并发症的策略。